| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2015-06-05 | SABBY MANAGEMENT, LLC | RXi Pharmaceuticals Corp | 2,750,000 | 4.2% | EDGAR |
| SC 13G | 2015-06-01 | Empery Asset Management, LP | RXi Pharmaceuticals Corp | 4,500,000 | 7.9% | EDGAR |
| SC 13G/A | 2015-02-25 | Advanced RNA Technologies, LLC | RXi Pharmaceuticals Corp | 1,294,015 | 9.7% | EDGAR |
| SC 13G/A | 2015-02-25 | Advanced RNA Technologies, LLC | RXi Pharmaceuticals Corp | 1,221,723 | 5.5% | EDGAR |
| SC 13G | 2015-02-25 | Advanced RNA Technologies, LLC | RXi Pharmaceuticals Corp | 41,259,266 | 12.8% | EDGAR |
| SC 13G/A | 2015-01-27 | TANG CAPITAL PARTNERS LP | RXi Pharmaceuticals Corp | 2,236,438 | 9.9% | EDGAR |
| SC 13G/A | 2014-10-03 | RTW INVESTMENTS, LLC | RXi Pharmaceuticals Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2014-02-14 | Broadfin Capital, LLC | RXi Pharmaceuticals Corp | 1,126,482 | 9.6% | EDGAR |
| SC 13G/A | 2014-01-16 | TANG CAPITAL PARTNERS LP | RXi Pharmaceuticals Corp | 1,298,094 | 9.9% | EDGAR |
| SC 13D | 2013-03-22 | Opko Health, Inc. | RXi Pharmaceuticals Corp | 67,241,380 | 20.9% | EDGAR |
| SC 13G | 2013-03-19 | Broadfin Capital, LLC | RXi Pharmaceuticals Corp | 31,034,483 | 9.6% | EDGAR |
| SC 13G | 2013-03-18 | TANG CAPITAL PARTNERS LP | RXi Pharmaceuticals Corp | 32,677,161 | 9.9% | EDGAR |
| SC 13G | 2012-07-09 | RTW INVESTMENTS, LLC | RXi Pharmaceuticals Corp | 14,186,638 | 10.0% | EDGAR |